Published in Cancer Weekly, March 9th, 1998
Kytril Tablets are indicated for the prevention of chemotherapy-induced nausea and vomiting in cancer patients. Until 1998, Medicare patients were only reimbursed for oral antiemetics administered with select oral chemotherapies.
Kytril Tablets are one of the few oral medications reimbursed by Medicare in a hospital outpatient setting or physician's office. This change is especially significant since the majority of cancer patients receive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly